Cargando…
Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Response to Letter]
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884955/ https://www.ncbi.nlm.nih.gov/pubmed/33603477 http://dx.doi.org/10.2147/CMAR.S304083 |
_version_ | 1783651523062923264 |
---|---|
author | Yang, Xin Zhu, Ying Zhao, Xia Li, Jian-Hua Xu, Da Jia, Hu-Liang Zhang, Jubo |
author_facet | Yang, Xin Zhu, Ying Zhao, Xia Li, Jian-Hua Xu, Da Jia, Hu-Liang Zhang, Jubo |
author_sort | Yang, Xin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7884955 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-78849552021-02-17 Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Response to Letter] Yang, Xin Zhu, Ying Zhao, Xia Li, Jian-Hua Xu, Da Jia, Hu-Liang Zhang, Jubo Cancer Manag Res Response to Letter Dove 2021-02-11 /pmc/articles/PMC7884955/ /pubmed/33603477 http://dx.doi.org/10.2147/CMAR.S304083 Text en © 2021 Yang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Response to Letter Yang, Xin Zhu, Ying Zhao, Xia Li, Jian-Hua Xu, Da Jia, Hu-Liang Zhang, Jubo Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Response to Letter] |
title | Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Response to Letter] |
title_full | Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Response to Letter] |
title_fullStr | Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Response to Letter] |
title_full_unstemmed | Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Response to Letter] |
title_short | Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Response to Letter] |
title_sort | hepatocellular carcinoma with portal vein tumor thrombus versus hepatocellular carcinoma with biliary tumor thrombus: better or worse prognoses? [response to letter] |
topic | Response to Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884955/ https://www.ncbi.nlm.nih.gov/pubmed/33603477 http://dx.doi.org/10.2147/CMAR.S304083 |
work_keys_str_mv | AT yangxin hepatocellularcarcinomawithportalveintumorthrombusversushepatocellularcarcinomawithbiliarytumorthrombusbetterorworseprognosesresponsetoletter AT zhuying hepatocellularcarcinomawithportalveintumorthrombusversushepatocellularcarcinomawithbiliarytumorthrombusbetterorworseprognosesresponsetoletter AT zhaoxia hepatocellularcarcinomawithportalveintumorthrombusversushepatocellularcarcinomawithbiliarytumorthrombusbetterorworseprognosesresponsetoletter AT lijianhua hepatocellularcarcinomawithportalveintumorthrombusversushepatocellularcarcinomawithbiliarytumorthrombusbetterorworseprognosesresponsetoletter AT xuda hepatocellularcarcinomawithportalveintumorthrombusversushepatocellularcarcinomawithbiliarytumorthrombusbetterorworseprognosesresponsetoletter AT jiahuliang hepatocellularcarcinomawithportalveintumorthrombusversushepatocellularcarcinomawithbiliarytumorthrombusbetterorworseprognosesresponsetoletter AT zhangjubo hepatocellularcarcinomawithportalveintumorthrombusversushepatocellularcarcinomawithbiliarytumorthrombusbetterorworseprognosesresponsetoletter |